SMX Backs Its “Truth Layer” With $50M in New Capital as Global Mandates Grow
Stock Market Today: Dow, S&P 500, Nasdaq Slip as Iran Standoff and Inflation Fears Pressure Stocks
U.S. stocks traded lower on Tuesday as investors dealt with a worsening diplomatic impasse between Washington and Tehran while preparing for a closely watched inflation report later this week.
Stock Market Today: Nasdaq Leads Gains as Weak July Jobs Report Reshapes Fed Outlook
Stock Market Today: Dow Slips as Earnings Keep Investors on Edge Despite Hormuz Optimism
Business & Market Movers

Strategy Sells More Bitcoin as Michael Saylor Shifts From Accumulation to Balance-Sheet Defense
·Aug 10, 2026Breaking News
Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled “Low Glycemic Sugar Composition.”
Impact Biomedical Inc. (IBIO), in which DSS Inc.(NYSE American: DSS) has a significant investment, is thrilled to announce a milestone in its innovative Laetose™ technology platform. The U.S. Patent and Trademark Office (USPTO) has issued U.S. patent # 11,898,184, entitled “Low Glycemic Sugar Composition” developed within this platform.

Bruush Oral Care Inc. and Arrive Technology Inc. Announce Agreement and Plan of Merger
scdadmin·Dec 15, 2023Deep Dive & Research
Healthcare & Biotech
Eli Lilly Stock Climbs as GLP-1 Demand Fuels Higher Sales Outlook
Eli Lilly (LLY) shares surged on Wednesday after the pharmaceutical giant raised its full-year sales forecast and delivered second-quarter results that beat expectations.






Join our newsletter
Read and share new perspectives on just about any topic. Everyone’s welcome.- 01Create a free account
- 02Write your story

Tech & Energy
SMX Backs Its “Truth Layer” With $50M in New Capital as Global Mandates Grow
In the small-cap world of tech, having an innovative product means nothing if you run out of cash before the market catches up. But SMX (NASDAQ: SMX) just used the first half of 2026 to completely change its financial standing, raising $50.5 million under its SEPA program while cutting payables and loans down by 61% to $8.7 million.



Tech Stocks Face Critical Test as Microsoft and Meta Earnings Put AI Spending Under the Microscope



































